Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of an elusive SERPING1 deletion in a family with hereditary angioedema type I utilizing soft clipping. | Front Allergy | 2025 | 40313637 | PubTator, text mining | PubMed |
| Expression of C1q by Macrophages and Fibroblasts in Tumor Microenvironment Is Associated with Progression and Metastasis of Cutaneous Squamous Cell Carcinoma. | J Invest Dermatol | 2025 | 40311866 | PubTator, text mining | PubMed |
| Proteomic Profiling of Age-Related Proteins Following Extracorporeal Apheresis. | Horm Metab Res | 2025 | 40233791 | PubTator, text mining | PubMed |
| Impact of a Heterozygous C1RR301P/WT Mutation on Collagen Metabolism and Inflammatory Response in Human Gingival Fibroblasts. | Cells | 2025 | 40214433 | PubTator, text mining | PubMed |
| Health care providers' experiences with genetic testing in patients at risk for hereditary angioedema. | J Allergy Clin Immunol Glob | 2025 | 40201039 | PubTator, text mining | PubMed |
| Anti-C1s autoantibodies as complementary serologic biomarker in lupus nephritis. | Clin Immunol | 2025 | 40132784 | PubTator, text mining | PubMed |
| Intrinsic pathway activation in patients with antiphospholipid syndrome and healthy controls. | Res Pract Thromb Haemost | 2025 | 40093963 | PubTator, text mining | PubMed |
| Activated factor XI-antithrombin and thrombin-antithrombin complexes in the prediction of venous thromboembolism and mortality in patients with non-small-cell lung cancer. | J Thromb Haemost | 2025 | 40056983 | PubTator, text mining | PubMed |
| Mendelian randomization identifies proteins involved in neurodegenerative diseases. | Brain | 2025 | 40037332 | PubTator, text mining | PubMed |
| Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. | NPJ Precis Oncol | 2025 | 40032924 | PubTator, text mining | PubMed |
| Association between cancer-associated fibroblasts and prognosis of neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma: a bioinformatics analysis based on single-cell RNA sequencing. | Cancer Cell Int | 2025 | 40025479 | PubTator, text mining | PubMed |
| Urine complement analysis implies complement activation is involved in membranous nephropathy. | Front Med (Lausanne) | 2025 | 40018357 | PubTator, text mining | PubMed |
| Corrigendum: Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs. | Front Immunol | 2025 | 40013135 | PubTator, text mining | PubMed |
| Mechanosensitive adhesion G protein-coupled receptors: Insights from health and disease. | Genes Dis | 2025 | 39935605 | PubTator, text mining | PubMed |
| Rare and common single nucleotide variants in childhood-onset systemic lupus erythematosus. | Lupus Sci Med | 2025 | 39933823 | PubTator, text mining | PubMed |
| Complement function and activation in human serum and plasma collected in different blood collection tubes. | J Immunol Methods | 2025 | 39921078 | PubTator, text mining | PubMed |
| Evaluating SCUBE-1 as Predictive Biomarker for Hypertension-Mediated Organ Damage: A Comparative Study. | Rev Cardiovasc Med | 2025 | 39867205 | PubTator, text mining | PubMed |
| [Berberine ameliorates coronary artery endothelial cell injury in Kawasaki disease through complement and coagulation cascades]. | Zhongguo Dang Dai Er Ke Za Zhi | 2025 | 39825659 | PubTator, text mining | PubMed |
| N-glycosylation in the SERPIN domain of the C1-esterase inhibitor in hereditary angioedema. | JCI Insight | 2025 | 39823539 | PubTator, text mining | PubMed |
| Complement classical and alternative pathway activation contributes to diabetic kidney disease progression: a glomerular proteomics on kidney biopsies. | Sci Rep | 2025 | 39753879 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=6